Discounted Cash Flow (DCF) Analysis Unlevered

HOOKIPA Pharma Inc. (HOOK)

$1.73

-0.07 (-3.89%)
All numbers are in Millions, Currency in USD
Stock DCF: - | 1.73 | undervalue

Operating Data

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue ----------
Revenue (%)
EBITDA ----------
EBITDA (%)
EBIT ----------
EBIT (%)
Depreciation ----------
Depreciation (%)

Balance Sheet Data

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash ----------
Total Cash (%)
Account Receivables ----------
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable ----------
Accounts Payable (%)
Capital Expenditure ----------
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 1.73
Beta 1.046
Diluted Shares Outstanding 26.08
Cost of Debt
Tax Rate 0.00
After-tax Cost of Debt -16.06%
Risk-Free Rate
Market Risk Premium
Cost of Equity 8.060
Total Debt 5.59
Total Equity 45.13
Total Capital 50.72
Debt Weighting 11.03
Equity Weighting 88.97
Wacc

Build Up Free Cash

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue ----------
EBITDA ----------
EBIT ----------
Tax Rate -0.03%-0.15%0.00%0.00%0.00%-0.04%-0.04%-0.04%-0.04%-0.04%
EBIAT ----------
Depreciation ----------
Accounts Receivable ----------
Inventories ----------
Accounts Payable ----------
Capital Expenditure -1.30-2.15-2-2.37------
UFCF ----------
WACC
PV UFCF -----
SUM PV UFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 5.40
Free cash flow (t + 1) -
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt -60.33
Equity Value -
Shares Outstanding 26.08
Equity Value Per Share -